Allena Pharmaceuticals (ALNA) Financials

$0.01

$0.00 (-10.40%)

As on 09-Nov-2022 09:30EDT

Market cap

$9 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	25.37	31.99	31.99	46.92	35.59	20.95
Operating Profit (EBIT)	-41.03	-47.65	-31.99	-46.92	-35.59	-20.95
Other Income	--	--	-0.86	0.19	--	-0.70
Profit before Tax	-27.49	-32.85	-32.85	-47.34	-35.65	-21.65
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-27.49	-32.85	-32.85	-47.34	-35.65	-21.65
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-43.30	-48.66	-32.85	-47.34	-35.65	-21.71

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	3.74	18.87	22.57	17.20	49.46	82.87
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.65	0.21	10.24	6.00	10.01	5.84
Current Liabilities	10.43	15.68	6.12	10.91	5.76	7.54
Total Liabilities	28.24	34.76	38.93	34.11	65.23	96.25

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	1.33	1.75	1.68	1.07	0.76	0.22
Current Assets	16.49	33.01	37.25	33.04	64.47	96.03
Total Assets	28.24	34.76	38.93	34.11	65.23	96.25
Total Debt*	0.38	0.53	10.14	10.48	9.98	9.39
Net Current Assets	6.06	17.33	31.13	22.13	58.71	88.49

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-45.68	-28.16	-43.63	-31.84	-21.07
Cash Flow from Investing Activities	--	-0.67	-0.63	-0.12	-0.32	23.42
Cash from Financing Activities	--	41.29	33.83	12.12	-0.69	66.89
Net Cash Inflow / Outflow	--	--	5.04	-31.64	-32.85	69.24

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-126.07	-108.78	-108.69	-47.00	-101.73
ROE (%)	-243.13	-158.53	-165.19	-142.04	-53.88	-183.53
ROA (%)	-82.89	-89.15	-89.94	-95.31	-44.15	-29.71
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	3,823.63	-25,451.08	--	3,092.86
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	40.99	--	31.83	-31.82	-69.89	13.38
Net Profit Growth (%)	37.38	--	30.62	-32.80	-64.66	11.66
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.86	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.13	0.93	0.78	0.42	1.45	4.08
Close Price ($)	0.19	0.59	1.28	2.73	5.45	10.06
High Price ($)	1.45	2.78	3.39	9.60	17.56	15.40
Low Price ($)	0.07	0.58	0.53	1.55	4.80	8.66
Market Cap ($ Cr)	9.16	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.03	0.45	0.61	0.20	0.11
Short term debt to equity ratio	0.10	0.02	0.01	0.26	--	0.05
Current Ratio	1.58	2.11	6.08	3.03	11.19	12.73
Quick Ratio	1.58	--	--	--	--	12.73
Interest Coverage	-31.53	-62.72	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.